About this trial
The primary aim of this study is to rigorously compare the efficacy of two commonly used endometrial sampling devices, the Pipelle and the Miltex, these devices are standard of care at Maimonides. This primary objective is critical, as the ability to accurately reach the uterine cavity is fundamental to obtaining adequate samples for histopathological evaluation, which is crucial for diagnosing endometrial cancer and other uterine pathologies.
Eligibility criteria
Qualifiers
Patients <18- 45 years with risk factors for endometrial cancer requiring endometrial biopsy.
Patients ≥ 45 -95 years with abnormal uterine bleeding.
Postmenopausal patients with bleeding or suspected endometrial pathology
Disqualifiers
Any patient who does not meet the inclusion criteria.
Pregnancy
Acute pelvic inflammatory disease
Acute cervical infection
Trial design
Treatments tested in this trial
- Curved Tip Aspirator
- Pipelle